Latent Pulmonary Inflammation in Patients With Systemic Sclerosis

Archivos de Bronconeumología - Tập 48 - Trang 8-13 - 2012
Sara Sánchez-Vidaurre1,2,3, Carmen Pilar Simeón4, Maria Jesús Cruz1,2, Vicente Fonollosa4, Miguel Vilardell4, Ferran Morell1,2, Xavier Muñoz1,2,5
1Servei de Pneumologia, Hospital Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBER Enfermedades Respiratorias (CIBERES)
3Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
4Servei de Medicina Interna, Hospital Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
5Departamento de Biología Celular, Fisiología, Inmunología, Universitat Autònoma de Barcelona, Barcelona, Spain

Tài liệu tham khảo

White, 2003, Interstitial lung disease in scleroderma, Rheum Dis Clin North Am, 29, 371, 10.1016/S0889-857X(03)00025-5 Jacobsen, 2001, Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis, J Rheumatol, 28, 2454 Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma, Arthritis Rheum, 43, 2437, 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U Altman, 1991, Predictors of survival in systemic sclerosis (scleroderma), Arthritis Rheum, 34, 403, 10.1002/art.1780340405 Hubbard, 2002, The impact of coexisting connective tissue disease on survival on patients with fibrosing alveolitis, Rheumatology (Oxford), 41, 676, 10.1093/rheumatology/41.6.676 Simeón, 1997, Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis, Ann Rheum Dis, 56, 723, 10.1136/ard.56.12.723 Lee, 1992, Mortality in systemic sclerosis (scleroderma), Q J Med, 298, 139 Latsi, 2003, Evaluation and management of alveolitis and interstitial lung disease in scleroderma, Curr Opin Rheumatol, 15, 748, 10.1097/00002281-200311000-00011 Behr, 2008, Pulmonary function tests, Rheumatol, 47, v65, 10.1093/rheumatology/ken313 Antoniou, 2008, Scleroderma lung disease: evolving understanding in light of newer studies, Curr Opin Rheumatol, 20, 686, 10.1097/BOR.0b013e3283126985 Wells, 2008, High-resolution computed tomography and scleroderma lung disease, Rheumatol, 47, v59, 10.1093/rheumatology/ken271 Harrison, 1989, Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance, Respir Med, 83, 403, 10.1016/S0954-6111(89)80072-1 Siver, 2008, Histopathology and bronchoalveolar lavage, Rheumatology, 47, v62, 10.1093/rheumatology/ken272 Strange, 2008, Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease, Am J Respir Crit Care Med, 177, 91, 10.1164/rccm.200705-655OC Pizzichini, 1996, Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements, Am J Respir Crit Care Med, 154, 308, 10.1164/ajrccm.154.2.8756799 Brightling, 2006, Clinical applications of induced sputum, Chest, 129, 1344, 10.1378/chest.129.5.1344 Tillie-Leblond, 2009, Relation between inflammation and symptoms in asthma, Allergy, 64, 354, 10.1111/j.1398-9995.2009.01971.x Beeh, 2004, Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD, Chest, 126, 1116, 10.1378/chest.126.4.1116 D’Ippolito, 1999, Induced sputum in patients with newly diagnosed sarcoidosis, Chest, 115, 1611, 10.1378/chest.115.6.1611 Bellido-Casado, 2011, Inflamación bronquial, clínica respiratoria y función pulmonar en el síndrome de Sjögren primario, Arch Bronconeumol, 47, 330, 10.1016/j.arbres.2011.01.003 Damjanov, 2009, Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage, Respiration, 78, 56, 10.1159/000164720 Vatrella, 2007, Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement, Respir Med, 101, 1383, 10.1016/j.rmed.2007.02.003 LeRoy, 1988, Sclerodermia (systemic sclerosis) classification, subsets and pathogenesis, J Rheumatol, 15, 202 Miller, 2005, ATS/ERS task force, standardization of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 Wanger, 2005, Standardization of the measurement of lung volumes, Eur Respir J, 26, 511, 10.1183/09031936.05.00035005 Macintyre, 2005, Standardisation of the single-breath determination of carbon monoxide uptake in the lung, Eur Respir J, 26, 720, 10.1183/09031936.05.00034905 Roca, 1986, Spirometric reference values from a Mediterranean population, Bull Eur Physiopathol Respir, 22, 217 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J, 26, 948, 10.1183/09031936.05.00035205 Rodriguez-Roisin, 1998, Normativa sobre gasometría arterial, Arch Bronconeumol, 34, 142, 10.1016/S0300-2896(15)30471-3 2002, ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, 166, 111, 10.1164/ajrccm.166.1.at1102 Wells, 2009, Pulmonary complications: one of the most challenging complications of systemic sclerosis, Rheumatology, 48, iii40, 10.1093/rheumatology/kep109 Fireman, 2006, Induced sputum in interstitial lung diseases, Curr Opin Pulm Med, 12, 318, 10.1097/01.mcp.0000239547.62949.82 Goh, 2007, Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression, Arthritis Rheum, 56, 2005, 10.1002/art.22696 Spanevello, 1997, Induced sputum to assess airway inflammation: a study of reproducibility, Clin Exp Allergy, 27, 1138, 10.1111/j.1365-2222.1997.tb01150.x Belda, 2000, Induced sputum cell counts in healthy adults, Am J Respir Crit Care Med, 161, 475, 10.1164/ajrccm.161.2.9903097 Yilmaz, 2011, Induced sputum as am method for detection of systemic sclerosis-related interstitial lung disease, Rheumathol Int, 10.1007/s00296-011-1872-4 Ferri, 2002, Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients, Medicine (Baltimore), 81, 139, 10.1097/00005792-200203000-00004 Steen, 1992, Isolated diffusing capacity reduction in systemic sclerosis, Arthritis Rheum, 35, 765, 10.1002/art.1780350709 Steen, 2003, Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement, Arthritis Rheum, 48, 516, 10.1002/art.10775 Weaver, 1968, Pulmonary scleroderma, Dis Chest, 54, 490, 10.1378/chest.54.6.490 Guttadauria, 1977, Pulmonary function in scleroderma, Arthritis Rheum, 20, 1071, 10.1002/art.1780200506 Catterall, 1963, Respiratory function in progressive systemic sclerosis, Thorax, 18, 10, 10.1136/thx.18.1.10 Hughes, 2003, The single breath transfer factor (TLCO) and the transfer coefficient (KCO): a window onto the pulmonary microcirculation, Clin Physiol Funct Imaging, 23, 63, 10.1046/j.1475-097X.2003.00482.x Thomas, 2005, The influence of age on induced sputum differential cell counts in normal subjects, Chest, 128, 4049